National Institute on Drug Abuse; Notice of Closed Meeting, 63996-63997 [2013-25056]
Download as PDF
<![CDATA[
63996
Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices
Dated: October 21, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–25055 Filed 10–24–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
MD 20892–7616, 301–594–3193,
uday.shankar@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Preclinical Innovation
Program.
Date: October 31–November 1, 2013.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Jane K. Battles, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Room 3128,
Bethesda, MD 20892–7616, 301–451–2744,
battlesja@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Weiqun Li, MD, Scientific
Review Officer, National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Blvd., Suite 703H, Bethesda, MD
20892, (301) 594–5966, wli@mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the Government shutdown of October
2013.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: October 21, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Place: National Institutes of Health,
Building 31, Room 2A48, 31 Center Drive,
Bethesda, MD 20892.
Contact Person: Constantine A. Stratakis,
MD, D(med)Sci, Scientific Director, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, NIH,
Building 31, Room 2A46, 31 Center Drive,
Bethesda, MD 20892, 301–594–5984,
stratakc@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/meetings/2013/
Pages/120613.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2013–25028 Filed 10–24–13; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
emcdonald on DSK67QTVN1PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Preclinical Development
Services for AIDS Therapeutics.
Date: October 30, 2013.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Uday K. Shankar, Ph.D.,
MSC, Scientific Review Officer, Scientific
Review Program, DEAS/NIAID/NIH/DHHS,
6700B Rockledge Drive, MSC 7616, Bethesda,
VerDate Mar<15>2010
17:55 Oct 24, 2013
Jkt 232001
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Initial Review Group.
Date: November 4–5, 2013.
Time: 8:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Dated: October 21, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–25052 Filed 10–24–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Quantification of Drugs of Abuse and Related
Substances in Biological Specimens (7788).
Date: November 7, 2013.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the Government shutdown of October
2013.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
E:\FR\FM\25OCN1.SGM
25OCN1
Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: October 21, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–25056 Filed 10–24–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Kidney, Urologic, and Hematologic
Diseases Interagency Coordinating
Committee; Urology Subcommittee
Workshop
The Urology Subcommittee of
the Kidney, Urologic, and Hematologic
Diseases Interagency Coordinating
Committee (KUHICC) will hold a 1-day
workshop on November 4, 2013. The
workshop will be open to the public,
with attendance limited to space
available.
SUMMARY:
The workshop will be held on
November 4, 2013, from 8:00 a.m. to
3:30 p.m. Requests for registration must
occur 7 days prior to the workshop.
DATES:
The workshop will be at the
National Institutes of Health, Office of
Research on Women’s Health, Room
401, 6707 Democracy Boulevard,
Rockville, MD 20817.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
For
further information concerning this
workshop, contact Dr. Tamara
Bavendam, Co-Chair, Kidney, Urologic,
and Hematologic Diseases Interagency
Coordinating Committee—Urology
Subcommittee, National Institute of
Diabetes and Digestive and Kidney
Diseases, 6707 Democracy Boulevard,
Bethesda, Room 615, MSC 5458,
Bethesda, MD 20892–5458, telephone:
301–594–4733; email:
tamara.bavendam@nih.gov.
The
KUHICC facilitates cooperation,
communication, and collaboration on
kidney, urologic, and hematologic
diseases among government entities.
The November 4, 2013, workshop held
by the KUHICC Urology Subcommittee,
also called the ‘‘Urology Interagency
Coordinating Committee (UICC), will
discuss research needs and new
directions in women’s urologic health
that can assist the NIDDK in
development of a new Women’s
Urologic Health Research Program. An
agenda for this workshop is available by
contacting Dr. Tamara Bavendam, email:
tamara.bavendam@nih.gov.
emcdonald on DSK67QTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
17:55 Oct 24, 2013
Jkt 232001
63997
Any interested person may file
written comments with the Committee
by forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
workshop, there will not be time on the
agenda for oral comments from
members of the public.
Please note that seating is limited and
attendance will be first-come, firstserved. Non-federal individuals
planning to attend the workshop should
register by email to Dr. Tamara
Bavendam, email: tamara.bavendam@
nih.gov and John Hare, The Scientific
Consulting Group, Inc. (jhare@
scgcorp.com) after October 15, 2013.
Please put ‘‘Registration UICC Nov 4
Meeting’’ in the subject line. Request for
registration should occur at least 7 days
prior to the workshop. Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should inform the
Contact Person listed below at least 10
days in advance of the workshop.
Emphasis Panel; Autoimmunity Centers of
Excellence, Basic and Clinical Components.
Date: November 18–19, 2013.
Time: November 18, 2013, 8:00 a.m. to 6:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Time: November 19, 2013, 8:00 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Paul A. Amstad, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 30, 2013.
Griffin P. Rodgers,
Director, National Institute of Diabetes and
Digestive and Kidney Diseases, National
Institutes of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–25278 Filed 10–24–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Dated: October 21, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–25029 Filed 10–24–13; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Training and Career Development.
Date: November 7, 2013.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Suite 703K, 6701
Democracy Boulevard, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Yujing Liu, Ph.D., MD,
Chief, Office of Review, Division of
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Pages 63996-63997]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25056]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Quantification of Drugs of Abuse and Related
Substances in Biological Specimens (7788).
Date: November 7, 2013.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Lyle Furr, Scientific Review Officer, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 435-1439, lf33c.nih.gov.
This meeting notice is being published less than 15 days in
advance of the meeting due to the Government shutdown of October
2013.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and
[[Page 63997]]
Addiction Research Programs, National Institutes of Health, HHS)
Dated: October 21, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-25056 Filed 10-24-13; 8:45 am]
BILLING CODE 4140-01-P
